Flossbach Von Storch SE’s Thermo Fisher Scientific Inc Position
Does Flossbach Von Storch SE own Thermo Fisher Scientific Inc (TMO)? Yes — 1.95M shares worth $960M (+4.48% of its 13F portfolio) as of Q1 2026, down from 2.18M shares the prior filed quarter.
Position Value
$960M
Q1 2026
Shares
1.95M
% of Portfolio
+4.48%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.95M | $960M | +4.48% |
| Q4 2025 | 2.18M | $1.3B | +5.00% |
| Q3 2025 | 2.52M | $1.2B | +4.81% |
| Q2 2025 | 2.73M | $1.1B | +4.52% |
| Q1 2025 | 1.41M | $703M | +3.04% |
| Q4 2024 | 1.34M | $695M | +2.76% |
| Q3 2024 | 1.33M | $822M | +3.22% |
| Q2 2024 | 1.32M | $731M | +3.06% |
| Q1 2024 | 1.34M | $778M | +3.39% |
| Q4 2023 | 1.35M | $719M | +3.28% |
| Q3 2023 | 1.26M | $640M | +2.82% |
| Q2 2023 | 1.01M | $526M | +2.12% |
| Q1 2023 | 930.4K | $536M | +2.26% |
| Q4 2022 | 1.16M | $636M | +2.43% |
| Q3 2022 | 1.15M | $585M | +2.15% |
| Q2 2022 | 1.13M | $612M | +2.05% |
| Q1 2022 | 962.5K | $569M | +1.59% |
| Q4 2021 | 805.5K | $537M | +1.45% |
| Q3 2021 | 798.6K | $456M | +1.33% |
| Q2 2021 | 796.7K | $402M | +1.20% |
| Q1 2021 | 345.5K | $158M | +0.56% |
| Q4 2020 | 111.0K | $52M | +0.21% |
| Q3 2020 | 156.9K | $69M | +0.34% |
| Q2 2020 | 168.0K | $61M | +0.32% |
| Q1 2020 | 167.0K | $47M | +0.32% |
| Q4 2019 | 89.3K | $29M | +0.20% |
| Q3 2019 | 66.4K | $19M | +0.15% |
| Q2 2019 | 21.8K | $6M | +0.05% |
| Q1 2019 | 21.6K | $6M | +0.05% |
| Q4 2018 | 21.8K | $5M | +0.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Flossbach Von Storch SE’s full portfolio or all institutional holders of TMO.